Dendritic cells in tolerance induction for the treatment of autoimmune diseases
✍ Scribed by Maria Rescigno
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 248 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Autoimmune diseases are characterized by the loss of tolerance toward self‐antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a non‐specific fashion, which is inevitably accompanied by several side effects. Antigen‐specific immunomodulation and patient‐tailored therapies are likely to solve these issues and to elicit long‐term protection against disease flares. This Viewpoint analyzes the potential use of DC for induction of antigen‐specific tolerance in autoimmune disease settings.
📜 SIMILAR VOLUMES
Nuclear factor kB (NF-kB) is a family of structurally related transcription factors. In mammals, the NF-kB family consists of five members: NF-kB1 (p105/50), NF-kB2 (p100/52), RelA (p65), RelB and c-Rel. They all have a structurally conserved N-terminal 300-amino-acid Rel homology domain (RHD), whic
The vertebrate immune system has evolved to protect against invasive pathogens, but with this adaptation comes the risk of autoimmunity, the recognition and destruction of self tissues by cells of the immune system. To avoid this problem the system has evolved active mechanisms by which tolerance is